- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02294331
Attain Performa™ Left Ventricular (LV) Quadripolar Leads Chronic Performance Study
Attain Performa™ Left Ventricular Quadripolar Lead Post-Approval Study
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Leuven, Belgia
-
-
-
-
-
Calgary, Canada
-
Ottawa, Canada
-
Quebec, Canada
-
-
Alberta
-
Calgary, Alberta, Canada
-
-
Ontario
-
London, Ontario, Canada
-
-
Quebec
-
Montreal, Quebec, Canada
-
-
-
-
Alabama
-
Birmingham, Alabama, Forente stater, 35294
-
-
Alaska
-
Anchorage, Alaska, Forente stater, 99508
-
-
Arizona
-
Chandler, Arizona, Forente stater, 85226
-
Gilbert, Arizona, Forente stater, 85295
-
-
Arkansas
-
Jonesboro, Arkansas, Forente stater, 72410
-
-
California
-
Bakersfield, California, Forente stater, 93301
-
Rancho Mirage, California, Forente stater, 92270
-
Redwood City, California, Forente stater, 94062
-
Salinas, California, Forente stater, 93901
-
San Diego, California, Forente stater, 92103
-
Stanford, California, Forente stater, 94305
-
Torrance, California, Forente stater, 90503
-
Van Nuys, California, Forente stater, 91405
-
-
Colorado
-
Colorado Springs, Colorado, Forente stater, 80907
-
Lakewood, Colorado, Forente stater, 80228
-
-
Connecticut
-
New Haven, Connecticut, Forente stater, 06519
-
-
District of Columbia
-
Washington, District of Columbia, Forente stater, 20010
-
-
Florida
-
Bradenton, Florida, Forente stater, 34205
-
Clearwater, Florida, Forente stater, 33756
-
Jacksonville, Florida, Forente stater, 32216
-
Safety Harbor, Florida, Forente stater, 34695
-
-
Georgia
-
Albany, Georgia, Forente stater, 31701
-
Marietta, Georgia, Forente stater, 30060
-
-
Indiana
-
Evansville, Indiana, Forente stater, 47710
-
-
Iowa
-
West Des Moines, Iowa, Forente stater, 50266
-
-
Kansas
-
Kansas City, Kansas, Forente stater, 66160
-
-
Kentucky
-
Edgewood, Kentucky, Forente stater, 41017
-
Lexington, Kentucky, Forente stater, 40503
-
Louisville, Kentucky, Forente stater, 40207
-
-
Louisiana
-
Baton Rouge, Louisiana, Forente stater, 70808
-
-
Maryland
-
Hyattsville, Maryland, Forente stater, 20782
-
Salisbury, Maryland, Forente stater, 21804
-
Silver Spring, Maryland, Forente stater, 20910
-
Takoma Park, Maryland, Forente stater, 20912
-
-
Michigan
-
Lansing, Michigan, Forente stater, 48912
-
Marquette, Michigan, Forente stater, 49855
-
Ypsilanti, Michigan, Forente stater, 48197
-
-
Minnesota
-
Minneapolis, Minnesota, Forente stater, 55407
-
Robbinsdale, Minnesota, Forente stater, 55422
-
Rochester, Minnesota, Forente stater, 554905
-
-
Mississippi
-
Hattiesburg, Mississippi, Forente stater
- Hattiesburg Clinic
-
-
Missouri
-
Columbia, Missouri, Forente stater, 65201
-
Kansas City, Missouri, Forente stater, 64111
-
Saint Louis, Missouri, Forente stater, 63110
-
-
Nevada
-
Las Vegas, Nevada, Forente stater, 89169
-
-
New Hampshire
-
Lebanon, New Hampshire, Forente stater, 03766
-
-
New Jersey
-
Morristown, New Jersey, Forente stater, 07960
-
-
New Mexico
-
Albuquerque, New Mexico, Forente stater, 87106
-
-
New York
-
Huntington, New York, Forente stater, 11743
-
New York, New York, Forente stater, 10032
-
Poughkeepsie, New York, Forente stater, 12601
-
Utica, New York, Forente stater, 13501
-
-
North Carolina
-
Charlotte, North Carolina, Forente stater, 28203
-
Durham, North Carolina, Forente stater, 27705
-
Raleigh, North Carolina, Forente stater, 27610
-
-
Ohio
-
Akron, Ohio, Forente stater, 44304
-
Cincinnati, Ohio, Forente stater, 45219
-
Cleveland, Ohio, Forente stater, 44195
-
Toledo, Ohio, Forente stater, 43608
-
-
Oregon
-
Portland, Oregon, Forente stater, 97220
-
-
Pennsylvania
-
Allentown, Pennsylvania, Forente stater, 18103
-
Bethlehem, Pennsylvania, Forente stater
- St Luke's University Health Network
-
Danville, Pennsylvania, Forente stater, 17822
-
Erie, Pennsylvania, Forente stater, 16550
-
Philadelphia, Pennsylvania, Forente stater, 19104
-
Pittsburgh, Pennsylvania, Forente stater, 15213
-
Wilkes-Barre, Pennsylvania, Forente stater, 18711
-
-
Tennessee
-
Germantown, Tennessee, Forente stater, 38138
-
Nashville, Tennessee, Forente stater, 37203
-
-
Texas
-
Austin, Texas, Forente stater, 78705
-
Dallas, Texas, Forente stater, 75226
-
Fort Worth, Texas, Forente stater, 76104
-
Houston, Texas, Forente stater, 77030
-
Plano, Texas, Forente stater, 75093
-
The Woodlands, Texas, Forente stater, 77384
-
-
Vermont
-
Burlington, Vermont, Forente stater, 05401
-
-
Virginia
-
Falls Church, Virginia, Forente stater, 22042
-
Leesburg, Virginia, Forente stater, 20176
-
-
Washington
-
Spokane, Washington, Forente stater, 99204
-
-
Wisconsin
-
Madison, Wisconsin, Forente stater, 53715
-
Milwaukee, Wisconsin, Forente stater, 53215
-
-
-
-
-
La Rochelle, Frankrike
-
Nantes, Frankrike
-
-
-
-
-
Eindhoven, Nederland
-
Maastricht, Nederland
-
Nieuwegein, Nederland
-
Rotterdam, Nederland
-
-
-
-
-
Liverpool, Storbritannia
-
Middlesbrough, Storbritannia
-
-
-
-
-
Zurich, Sveits
-
-
-
-
-
Essen, Tyskland
-
Hannover, Tyskland
-
Ulm, Tyskland
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Patients who meet all of the following inclusion criteria and do not meet any of the following exclusion criteria are eligible for enrollment.
Inclusion Criteria
- Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- Patient has or is intended to receive an Attain Performa™ LV lead
- Patient within 30 day post implant enrollment window
Exclusion Criteria
- Patient who is, or is expected to be inaccessible for follow-up
- Patient with exclusion criteria required by local law
- Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
---|
Attain Performa™ LV Leads
Patients who meet all Inclusion criteria and no Exclusion criteria and are implanted with an Attain Performa™ LV lead.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Lead complication
Tidsramme: 5 years
|
Survival analysis will be used to analyze the lead. Lead status will be reported as a function of time post-implant for all leads in the study. Lead related complications include but are not limited to: failure to capture, abnormal sensing, threshold rise, abnormal impedance, insulation breach, conductor fracture, extracardiac stimulation, lead dislodgement, cardiac perforation, structural lead failure. |
5 years
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Types of lead-related adverse device effects
Tidsramme: 5 years
|
Summary statistics will be used to report types and rates of lead related adverse device effects (ADE).
Examples of ADEs include but are not limited to: failure to capture, abnormal sensing, threshold rise, abnormal impedance, insulation breach, conductor fracture, extracardiac stimulation, lead dislodgement, cardiac perforation, structural lead failure.
|
5 years
|
Returned lead analysis
Tidsramme: 5 years
|
A listing of analysis results of all Attain Performa study leads which are explanted and returned for analysis will be reported.
|
5 years
|
Lead survival estimate by model
Tidsramme: 5 years
|
An analysis will be conducted at the end of the study to provide comparative statistics on the safety performance of each individual lead model.
|
5 years
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- Attain Performa™ PAS
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Hjertefeil
-
Region SkanePåmelding etter invitasjonHjertesvikt New York Heart Association (NYHA) klasse II | Hjertesvikt New York Heart Association (NYHA) klasse IIISverige
-
Medical University of BialystokInstitute of Cardiology, Warsaw, Poland; Medical University of Lodz; Poznan... og andre samarbeidspartnereHar ikke rekruttert ennåHjertesvikt, systolisk | Hjertesvikt med redusert utkastningsfraksjon | Hjertesvikt New York Heart Association Klasse IV | Hjertesvikt New York Heart Association klasse IIIPolen
-
Luigi Sacco University HospitalIRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Padova; Università degli Studi di Ferrara og andre samarbeidspartnereRekrutteringAtrieflimmer | Block Complete HeartItalia, Belgia, Sveits
-
University of WashingtonAmerican Heart AssociationFullførtHjertesvikt, Kongestiv | Mitokondriell endring | Hjertesvikt New York Heart Association Klasse IVForente stater
-
Novartis PharmaceuticalsFullførtPasienter som har fullført den 12-måneders behandlingsperioden i kjernestudien (de Novo Heart-mottakere) som var interessert i å bli behandlet med EC-MPS
-
University Hospital, GasthuisbergUkjentTransient Left Ventricular Ballooning SyndromeBelgia
-
NYU Langone HealthRekrutteringTako-tsubo kardiomyopati | Takotsubo kardiomyopati | Broken Heart SyndromeForente stater
-
French Cardiology SocietyFullført